These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6037061)

  • 1. The synthesis of potential anticancer agents. XXXVII. N-nitrosoureas. 3. 1,5-bis(2-chloroethyl)-1-nitrosobiuret and related derivatives of biurets, biureas, and carboxamides.
    Johnston TP; Opliger PS
    J Med Chem; 1967 Jul; 10(4):675-81. PubMed ID: 6037061
    [No Abstract]   [Full Text] [Related]  

  • 2. The synthesis of potential anticancer agents. XXXVI. N-nitrosoureas. II. Haloalkyl derivatives.
    Johnston TP; McCaleb GS; Opliger PS; Montgomery JA
    J Med Chem; 1966 Nov; 9(6):892-911. PubMed ID: 5972051
    [No Abstract]   [Full Text] [Related]  

  • 3. Nitrosoureas: 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962; BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC-79037; CCNU)--clinical brochure.
    Carter SK; Newman JW
    Cancer Chemother Rep 3; 1968 Dec; 1(1):115-51. PubMed ID: 4917773
    [No Abstract]   [Full Text] [Related]  

  • 4. 5-Fluorouracil (5-Fu; NSC-19893), 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388), vincristine (NSC-67574), and 1,3-bis(2-chloroethyl)-2-nitrosourea (BCNU; NSC-409962) given concomitantly in the treatment of solid tumors in man.
    van Eden EB; Falkson G; van Dyk JJ; van der Merwe AM; Falkson HC
    Cancer Chemother Rep; 1972 Feb; 56(1):107-47. PubMed ID: 5030803
    [No Abstract]   [Full Text] [Related]  

  • 5. 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and methotrexate (NSC-740) as combination therapy for advanced mouse leukemia L1210.
    Venditti JM; Kline I; Tyrer DD; Goldin A
    Cancer Chemother Rep; 1965 Oct; 48():35-9. PubMed ID: 5834736
    [No Abstract]   [Full Text] [Related]  

  • 6. Separate and sequential chemotherapy of mouse leukemia L1210 with 1-beta-D-arabinofuranosylcytosine hydrochloride and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Tyrer DD; Kline I; Venditti JM; Goldin A
    Cancer Res; 1967 May; 27(5):873-9. PubMed ID: 6025252
    [No Abstract]   [Full Text] [Related]  

  • 7. B.C.N.U. (1,3-bis (2-chloroethyl) -1-nitrosourea) in the treatment of advanced Hodgkin's disease.
    Cipriani D; Strinchini A
    Lancet; 1972 Jun; 1(7764):1345. PubMed ID: 4113442
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or cyclophosphamide on spleen colony-forming units and survival time of leukemic mice.
    Vadlamudi S; Waravdekar VS; Choudry JN; Goldin A
    Cancer Res; 1968 Jul; 28(7):1242-9. PubMed ID: 5665982
    [No Abstract]   [Full Text] [Related]  

  • 9. Structure-activity relationships: nitrosoureas.
    Johnston TP
    Cancer Chemother Rep 3; 1972 May; 3(1):50-1. PubMed ID: 5065660
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and cyclophosphamide (NSC-26271) on nicotinamide adenine dinucleotide glycohydrolase in normal and leukemic mouse tissues.
    Tsukagoshi S; Kao MH; Goldin A
    Cancer Chemother Rep; 1968 Sep; 52(5):569-78. PubMed ID: 5743704
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of advanced Hodgkin's disease with (1,3 bis (2-chloroethyl)-1-nitrosourea) BCNU.
    Young RC; DeVita VT; Serpick AA; Canellos GP
    N Engl J Med; 1971 Aug; 285(9):475-9. PubMed ID: 5558887
    [No Abstract]   [Full Text] [Related]  

  • 12. Isobutyl N-chloroethyl-N-nitrosocarbamate.
    Ross WC
    J Med Chem; 1967 Jan; 10(1):108-9. PubMed ID: 6031685
    [No Abstract]   [Full Text] [Related]  

  • 13. The response of human lymphoma cells in vitro to bleomycin and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Drewinko B; Novak JK; Barranco SC
    Cancer Res; 1972 Jun; 32(6):1206-8. PubMed ID: 4113143
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the management of patients with advanced breast cancer.
    Ahmann DL; Hahn RG; Bisel HF
    Cancer Chemother Rep; 1972 Feb; 56(1):93-4. PubMed ID: 5030810
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II study of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the treatment of bronchogenic carcinoma.
    Olshin S; Siddiqui S; Firat D
    Cancer Chemother Rep; 1972 Apr; 56(2):259-61. PubMed ID: 5043228
    [No Abstract]   [Full Text] [Related]  

  • 16. 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer.
    van Eden EB; Falkson HC; Falkson G
    Cancer Chemother Rep; 1970 Oct; 54(5):347-59. PubMed ID: 5514624
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors.
    Kinne DW; Humphrey EW
    Cancer Chemother Rep; 1972 Feb; 56(1):53-9. PubMed ID: 5030809
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of tumor-host differences at a single histocompatibility locus (H-1) on the antileukemic effect of 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC 409962).
    Bonmassar E; Cudkowicz G; Vadlamudi S; Goldin A
    Cancer Res; 1970 Oct; 30(10):2538-42. PubMed ID: 5474176
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of malignant brain tumors with nitrosoureas.
    Hansen HH; Muggia FM
    Cancer Chemother Rep; 1971 Apr; 55(2):99-100. PubMed ID: 4330275
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of combined therapy with cytosine arabinoside (NSC-63878) and l,3-bis-(2-chloroethyl)-1-nitrosourea (NSC-409962) on sarcoma 180 and L1210 in vivo.
    Mizuno NS; Humphrey EW
    Cancer Chemother Rep; 1969 Sep; 53(4):215-21. PubMed ID: 5384462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.